4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001873394-26-000003
President, Research & Develop. sold 25,907 shares at $15.39 ($398,810)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X06/wk-form4_1777937098.xml…